Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 7

1.

The MLLgnant consequences of reverting to an embryonic transcriptional program.

Jamieson C.

Cell Stem Cell. 2009 Feb 6;4(2):97-8. doi: 10.1016/j.stem.2009.01.008.

PMID:
19200795
2.

MLL leukemia and future treatment strategies.

Marschalek R.

Arch Pharm (Weinheim). 2015 Apr;348(4):221-8. doi: 10.1002/ardp.201400449. Epub 2015 Mar 4. Review.

PMID:
25740345
3.

MLL translocations, histone modifications and leukaemia stem-cell development.

Krivtsov AV, Armstrong SA.

Nat Rev Cancer. 2007 Nov;7(11):823-33. Review.

PMID:
17957188
4.

MLL1/WDR5 complex in leukemogenesis and epigenetic regulation.

Wu M, Shu HB.

Chin J Cancer. 2011 Apr;30(4):240-6. Review.

PMID:
21439245
5.

MLL: a histone methyltransferase disrupted in leukemia.

Hess JL.

Trends Mol Med. 2004 Oct;10(10):500-7. Review.

PMID:
15464450
6.

Transcriptional Regulation of the p16 Tumor Suppressor Gene.

Kotake Y, Naemura M, Murasaki C, Inoue Y, Okamoto H.

Anticancer Res. 2015 Aug;35(8):4397-401. Review.

PMID:
26168478
7.

The molecular biology of mixed lineage leukemia.

Slany RK.

Haematologica. 2009 Jul;94(7):984-93. doi: 10.3324/haematol.2008.002436. Epub 2009 Jun 16. Review.

PMID:
19535349

Supplemental Content

Support Center